On the use of wearable sensors as mobility biomarkers in the marketing authorization of new drugs: A regulatory perspective

The loss of mobility is a common trait in multiple health conditions (e.g., Parkinson's disease) and is associated with reduced quality of life. In this context, being able to monitor mobility in the real world, is important. Until recently, the technology was not mature enough for this; but to...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Viceconti, Marco, Tome, M, Dartee, Wim P, Knezevic, I, Hernandez Penna, S, Mazzà, Claudia, Caulfield, Brian, Garcia-Aymerich, Judith, Becker, Clemens, Maetzler, Walter, Troosters, Thierry, Sharrack, Basil, Davico, Giorgio, Corriol-Rohou, Solange, Rochester, Lynn, Mobilise-D, Consortium, Vereijken, Beatrix
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!